Don’t Come Around Here No More: A Drug Company Receives a Warning Letter for Limiting Inspection

by Arnall Golden Gregory LLP

In the “what were they thinking department,” a drug company located outside of the United States recently received a Warning Letter for limiting and refusing an FDA inspection. In addition, the agency placed the company on an Import Alert, not allowing the company’s products to be imported into the United States. Tom Petty and the Heartbreakers’ 1985 hit, “Don’t Come Around Here No More,” and the weird Alison in Wonderland video come to mind.

According to the Warning Letter, the company barred access to the quality control laboratory, directing “employees to stand shoulder-to-shoulder, barring our investigator from accessing portions of the laboratory and the equipment used to analyze drugs for U.S. distribution.” The company also refused to provide copies of complaint records. Finally, the investigator tried to take pictures of a piece of equipment used to manufacture the drugs, but the company official “impeded the inspection by preventing our investigator from photographing this piece of equipment.”

AGG Observations

  • A company should have procedures to handle inspections and not allow an investigator to roam unattended. However, FDA is allowed to review and copy those records concerning product manufacture, distribution, and handling. There are limits to FDA’s reach, such as access to pricing data but, in general, if the inspection or inquiry relates to quality-related concerns, FDA is entitled to access and will have the better argument if its inspection authority is challenged.
  • Barring or impeding an FDA inspection of areas where the agency is allowed to inspect is a prohibited act.
  • The issue of FDA taking photographs is more tricky. FDA believes it is allowed to take photographs, citing two court cases, but in our opinion neither one is directly on point. We recommend that companies make clear the reason photocopying in the plant is not allowed in the company’s standard operating procedures. In addition, firms should publicize and post a “no photos” policy at a facility. While an FDA investigator can disagree and insist, the investigator will frequently relent or at worst, ask for the name of the attorney who represents the company so that a follow-up discussion can occur. We cannot tell from the Warning Letter referenced above whether the company had such a policy or whether the investigator ignored a request not to photograph.
  • For companies or sites outside of the United States, there is no express statutory provision that permits FDA to inspect. However, the agency can detain or issue an Import Alert if it believes that an imported product “appears” to be unlawful. Thus, if FDA cannot inspect a facility to ensure compliance, it can tell a company that it does not have adequate assurances that the imported product is acceptable and, in an abundance of caution, detain the product. So, an ex-U.S. company normally allows the FDA inspection.
  • It is important that companies know their rights during an inspection and be trained accordingly. A firm is not required to give an investigator the keys to the facility and then leave the investigator with unfettered access. However, FDA has statutory authority to inspect facilities and review records, with limitations. Each company must balance the benefits and risks of restricting FDA access versus being cooperative. If a company decides it does not want (or is not required) to provide an FDA investigator with certain information, it is must be confident it is right on the law and consider alternatives to satisfying FDA’s request. An uncooperative company will often find itself the subject of a larger inspection, a Warning Letter, or both. On the other hand, an overly cooperative company that does not know FDA’s inspectional boundaries might be unduly harming itself through voluntary disclosure of information that FDA by law is not entitled to receive or review.
  • Procedures, training and a knowledge of the law are essential. But telling FDA “don’t come around here no more” is ill-advised.

To review the entire document and formatting for this alert (e.g., footnotes), please access the original below:



DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Arnall Golden Gregory LLP | Attorney Advertising

Written by:

Arnall Golden Gregory LLP

Arnall Golden Gregory LLP on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
Privacy Policy (Updated: October 8, 2015):

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.


JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at:

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.